AVTX (STOCKS)
Avalo Therapeutics, Inc. Common Stock
$14.000000
-0.610000 (-4.18%)
Prev close: $14.610000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Garry Arthur Neil
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $266.85M
- Employees
- 23
- P/E (TTM)
- -1.67
- P/B (TTM)
- 2.85
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-2.19 | $-1.69 | -0.4981 | -29.44% |
|
Jun 2025 (Q2)
|
$-1.92 | $-1.43 | -0.4869 | -33.98% |
|
Mar 2025 (Q1)
|
$-1.25 | $-1.41 | +0.1644 | +11.62% |
|
Dec 2024 (Q4)
|
$-7.95 | $-0.40 | -7.5505 | -1,889.99% |